| Bethany Mulder, DO | |
|
605 S Coolidge St, Moses Lake, WA 98837-1893 | |
| (509) 765-0674 | |
| (509) 764-0344 |
| Full Name | Bethany Mulder |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 8 Years |
| Location | 605 S Coolidge St, Moses Lake, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093176398 | NPI | - | NPPES |
| 2134374 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | OP60968552 (Washington) | Primary |
| 207Q00000X | Family Medicine | OP60968552 (Washington) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Samaritan Hospital | Moses lake, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kadlec Regional Medical Center | 9739098617 | 338 |
| Moses Lake Community Health Center | 1254235138 | 55 |
News Archive
Opexa Therapeutics, Inc., a company developing Tovaxin, a novel T-cell therapy for multiple sclerosis (MS), today reported financial results for the quarter ended September 30, 2011 and provided an overview of recent corporate developments.
Among obese patients, activation of the protein biomarker CTNNB1 was associated with better colorectal cancer-specific survival and overall survival, whereas post-diagnosis physical activity was associated with better colorectal cancer-specific survival among patients negative for CTNNB1, according to a study in the April 27 issue of JAMA.
EMS World Magazine, the leading monthly publication for the emergency medical services market, has announced the winners of the 2010 Top Innovation Awards, which recognize the industry's most innovative products of the year. The winners were chosen by industry expert and EMS World Magazine Editorial Advisory Board Member Mike Smith, BS, MICP. The awards will be presented at the Texas EMS State Conference in Austin, TX, November 21-24.
New research projects commissioned by the National Institute for Health Research's Health Technology Assessment (NIHR HTA) programme will evaluate the effectiveness and cost-effectiveness of different screening tests used in diabetic eye care.
› Verified 7 days ago
| Entity Name | Kadlec Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972507580 PECOS PAC ID: 9739098617 Enrollment ID: O20031104000035 |
News Archive
Opexa Therapeutics, Inc., a company developing Tovaxin, a novel T-cell therapy for multiple sclerosis (MS), today reported financial results for the quarter ended September 30, 2011 and provided an overview of recent corporate developments.
Among obese patients, activation of the protein biomarker CTNNB1 was associated with better colorectal cancer-specific survival and overall survival, whereas post-diagnosis physical activity was associated with better colorectal cancer-specific survival among patients negative for CTNNB1, according to a study in the April 27 issue of JAMA.
EMS World Magazine, the leading monthly publication for the emergency medical services market, has announced the winners of the 2010 Top Innovation Awards, which recognize the industry's most innovative products of the year. The winners were chosen by industry expert and EMS World Magazine Editorial Advisory Board Member Mike Smith, BS, MICP. The awards will be presented at the Texas EMS State Conference in Austin, TX, November 21-24.
New research projects commissioned by the National Institute for Health Research's Health Technology Assessment (NIHR HTA) programme will evaluate the effectiveness and cost-effectiveness of different screening tests used in diabetic eye care.
› Verified 7 days ago
| Entity Name | Moses Lake Community Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699862813 PECOS PAC ID: 1254235138 Enrollment ID: O20031121000667 |
News Archive
Opexa Therapeutics, Inc., a company developing Tovaxin, a novel T-cell therapy for multiple sclerosis (MS), today reported financial results for the quarter ended September 30, 2011 and provided an overview of recent corporate developments.
Among obese patients, activation of the protein biomarker CTNNB1 was associated with better colorectal cancer-specific survival and overall survival, whereas post-diagnosis physical activity was associated with better colorectal cancer-specific survival among patients negative for CTNNB1, according to a study in the April 27 issue of JAMA.
EMS World Magazine, the leading monthly publication for the emergency medical services market, has announced the winners of the 2010 Top Innovation Awards, which recognize the industry's most innovative products of the year. The winners were chosen by industry expert and EMS World Magazine Editorial Advisory Board Member Mike Smith, BS, MICP. The awards will be presented at the Texas EMS State Conference in Austin, TX, November 21-24.
New research projects commissioned by the National Institute for Health Research's Health Technology Assessment (NIHR HTA) programme will evaluate the effectiveness and cost-effectiveness of different screening tests used in diabetic eye care.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bethany Mulder, DO 605 S Coolidge St, Moses Lake, WA 98837-1893 Ph: (509) 765-0674 | Bethany Mulder, DO 605 S Coolidge St, Moses Lake, WA 98837-1893 Ph: (509) 765-0674 |
News Archive
Opexa Therapeutics, Inc., a company developing Tovaxin, a novel T-cell therapy for multiple sclerosis (MS), today reported financial results for the quarter ended September 30, 2011 and provided an overview of recent corporate developments.
Among obese patients, activation of the protein biomarker CTNNB1 was associated with better colorectal cancer-specific survival and overall survival, whereas post-diagnosis physical activity was associated with better colorectal cancer-specific survival among patients negative for CTNNB1, according to a study in the April 27 issue of JAMA.
EMS World Magazine, the leading monthly publication for the emergency medical services market, has announced the winners of the 2010 Top Innovation Awards, which recognize the industry's most innovative products of the year. The winners were chosen by industry expert and EMS World Magazine Editorial Advisory Board Member Mike Smith, BS, MICP. The awards will be presented at the Texas EMS State Conference in Austin, TX, November 21-24.
New research projects commissioned by the National Institute for Health Research's Health Technology Assessment (NIHR HTA) programme will evaluate the effectiveness and cost-effectiveness of different screening tests used in diabetic eye care.
› Verified 7 days ago
Evan Michael Graham, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 840 E Hill Ave, Moses Lake, WA 98837 Phone: 509-765-0216 | |
Dr. Tony E Yusuf, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 840 E Hill Ave, Moses Lake, WA 98837 Phone: 509-663-8711 | |
Klaus D Mergener, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 840 E Hill Ave, Moses Lake, WA 98837 Phone: 509-663-8711 | |
Dr. Stacy Kay Tong, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 840 E Hill Ave, Moses Lake, WA 98837 Phone: 509-663-8711 | |
Dr. David Thurn Earl, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1550 S Pioneer Way, Suite 200, Moses Lake, WA 98837 Phone: 509-765-1538 Fax: 509-765-7508 | |
Philip D Buckley, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 840 E Hill Ave, Moses Lake, WA 98837 Phone: 509-663-8711 |